LoginSignup
Lantheus Hldg logo

Lantheus Hldg

Stock
Stock
Ticker: LNTH
LNTH

Price

Price

CHART BY

Frequently asked questions

The market capitalization of Lantheus Hldg is $6.57B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Lantheus Hldg is 24.30. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Lantheus Hldg's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $4.138. EPS indicates the company's profitability on a per-share basis.
Currently, 10 analysts cover Lantheus Hldg's stock, with a consensus target price of $106.91. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Lantheus Hldg reported a revenue of $1.56B.
Lantheus Hldg's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $391.25M. EBITDA measures the company's overall financial performance.
Lantheus Hldg has a free cash flow of $387.83M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Lantheus Hldg employs approximately 1,193 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
The free float of Lantheus Hldg is 63.00M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$6.57B
EPS (TTM) 
$4.138
Free Float 
63.00M
P/E ratio (TTM) 
24.30
Revenue (TTM) 
$1.56B
EBITDA (TTM) 
$391.25M
Free Cashflow (TTM) 
$387.83M

Pricing

1D span
$100.46$101.56
52W span
$49.71$111.69

Analyst Ratings

The price target is $106.91 and the stock is covered by 10 analysts.

Buy

2

Hold

8

Sell

0

Information

Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the following geographical segments U.S. and International. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.

Employees
1,193
Industries
Medical Specialties
Sector
Health Care

Identifier

Primary Ticker
LNTH

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin